Overview

Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD

Status:
Completed
Trial end date:
2020-03-30
Target enrollment:
Participant gender:
Summary
This work will assess the prevalence in hard-to-treat ADHD of the ineffectiveness of the anesthetic Lidocaine.
Phase:
Early Phase 1
Details
Lead Sponsor:
PhenoSolve, LLC
Collaborators:
Boston Clinical Trials
NeurAbilities (formerly CRCNJ)
Treatments:
Lidocaine